Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Preliminary Results from a Phase 1/2 Study of DSP-7888, a Novel WT1 Peptide-Based Vaccine, in Patients with Myelodysplastic Syndrome (MDS)

Shigesaburo Miyakoshi, MD PhD, Kensuke Usuki, MD PhD, Itaru Matsumura, MD PhD, Yasunori Ueda, MD PhD, Hiromi Iwasaki, MD PhD, Toshihiro Miyamoto, MD PhD, Makoto Origuchi, Shuzo Tagashira, Ichiro Naoi, Tomoki Naoe, MD PhD, Masahiro Kizaki, MD PhD, Yuji Heike, MD PhD, Koichi Akashi, MD PhD, Yasushi Miyazaki, MD PhD

Blood (2016) 128 (22): 4335.

https://doi.org/10.1182/blood.V128.22.4335.4335

Published: 2016

Journal Articles

L-Asparaginase-Induced Allergy in Mice: Effects of Concomitant Drugs and Anti-IgE Antibody

Ai Nogami-Hara, PhD, Kazuki Hara, PhD, Yasuhiro Kawakami, PhD, Akira Shimada, MD PhD, Mitsunobu Mio, PhD

Blood (2016) 128 (22): 1632.

https://doi.org/10.1182/blood.V128.22.1632.1632

Published: 2016

Journal Articles

Next Generation XPO1 Inhibitor KPT-8602 for the Treatment of Drug-Resistant Multiple Myeloma

Joel G Turner, PhD, Jana L Dawson, BS, Christopher L Cubitt, PhD, Erkan Baluglo, PhD, Steven Grant, MD, Yun Dai, PhD, Kenneth H Shain, MD PhD, William S. Dalton, PhD MD, Sharon Shacham, William Senapedis, PhD, Daniel M Sullivan, MD

Blood (2015) 126 (23): 1818.

https://doi.org/10.1182/blood.V126.23.1818.1818

Published: 2015

Journal Articles

A Phase 1/2 Study of WT1 Peptide Cancer Vaccine WT4869 in Patients with Myelodysplastic Syndromes (MDS)

Takahiro Suzuki, MD PhD, Yasunori Ueda, MD PhD, Michinori Ogura, MD PhD, Toshiki Uchida, MD PhD, Keiya Ozawa, MD PhD, Shigesaburo Miyakoshi, MDPhD, Tomoki Naoe, MD PhD, Makoto Murata, MD PhD, Masahiro Kizaki, MD PhD, Naokuni Uike, MD, Yasunobu Abe, MD PhD, Michihiro Hidaka, MD PhD, Shuzo Tagashira, Satoru Tsuchiya, Kazuma Ohyashiki, MD PhD, Yasushi Miyazaki, MD PhD

Blood (2015) 126 (23): 2868.

https://doi.org/10.1182/blood.V126.23.2868.2868

Published: 2015

Journal Articles

Prevention Of Relapse In Acute Myeloid Leukemia By Dendritic Cell Vaccination: Report on a Phase II Study With 29 Patients

Zwi N. Berneman, MD, PhD, FRCP, Ann Van de Velde, MD, Sébastien Anguille, MD, Yannick Willemen, MD, Wilfried A. Schroyens, MD, PhD, Alain P. Gadisseur, MD, PhD, Inge Vrelust, MD, Griet Nijs, MT, Barbara Stein, MSc, Nathalie Cools, PhD, Ronald Malfait, MD, Marie-Berthe Maes, PharmD, PhD, Katrien Vermeulen, PhD, Viggo F. Van Tendeloo, PhD, Evelien L. Smits, PhD

Blood (2013) 122 (21): 236.

https://doi.org/10.1182/blood.V122.21.236.236

Published: 2013

Journal Articles

Human Umbilical Cord Blood (HUCB) Derived Pluripotent Stem Cells Enhances Wound Healing

Yanling Liao, PhD, Munenari Itoh, PhD, Samantha Roberts, Alexandra M Highet, Albert Yang, Angela Christiano, PhD, Mitchell S. Cairo, MD

Blood (2011) 118 (21): 4824.

https://doi.org/10.1182/blood.V118.21.4824.4824

Published: 2011

Journal Articles

WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia

Blood (2010) 116 (21): 16.

https://doi.org/10.1182/blood.V116.21.16.16

Published: 2010

Journal Articles

Peptide-Vaccine Treatment Associated with TKI Therapy in Patients with CML Is Able to Induce Immunologic, Cytogenetic and Molecular Responses: a Single Center Experience with Long-Term Follow up.

Elisabetta Abruzzese, Malgorzata Monika Trawinska, Angela Coletta, Serena Zaza, Roberta Giovagnorio, Giovanni Del Poeta, Micaela Ippoliti, Delfina Marzia, Paolo de Fabritiis, Francesco Lo Coco, Sergio Amadori, Monica Bocchia

Blood (2009) 114 (22): 2185.

https://doi.org/10.1182/blood.V114.22.2185.2185

Published: 2009

Journal Articles

Immunogenicity and Antileukemic Activity of Dendritic Cells Electroporated with Wilms’ Tumor WT1 mRNA: A Phase I/II Trial in Acute Myeloid Leukemia

Zwi N. Berneman, Ann Van de Velde, Ann Van Driessche, Nathalie Cools, Barbara Stein, Griet Nijs, Katrien Vermeulen, Katrien Pieters, Wilfried A. Schroyens, Alain P. Gadisseur, Inge Vrelust, I. Jolanda de Vries, David A. Price, Yusuke Oji, Haruo Sugiyama, Viggo F. Van Tendeloo

Blood (2008) 112 (11): 830.

https://doi.org/10.1182/blood.V112.11.830.830

Published: 2008

Journal Articles

Impact of Autologous Dendritic Cell Immunotherapy (Arcelis ™ ) on B Cell Subsets in HIV-1-Infected Subjects Receiving Antiretroviral Therapy

Mohamed-Rachid Boulassel, Bader Yassine-Diab, Don Healey, Charles Nicolette, Rafick-Pierre Sékaly, Jean Pierre Routy

Blood (2008) 112 (11): 80.

https://doi.org/10.1182/blood.V112.11.80.80

Published: 2008

Journal Articles

Vaccination of Acute Myeloid Leukemia Patients with Dendritic Cells Electroporated with mRNA Encoding the Wilms’ Tumor Protein WT1: A Phase I/II Trial.

Zwi N. Berneman, MD, PhD, Ann Van Driessche, M.Sc., Ann Van de Velde, M.D., Griet Nijs, M.T., Tessa Braeckman, M.Sc., Barbara Stein, M.Sc, Katrien Vermeulen, Ph.D., Katrien Pieters, Ph.D., Alain P. Gadisseur, M.D., Ph.D, Wilfried A. Schroyens, M.D., Ph.D., I. Jolanda de Vries, Ph.D., David A. Price, Ph.D., Viggo F. Van Tendeloo, Ph.D.

Blood (2007) 110 (11): 158.

https://doi.org/10.1182/blood.V110.11.158.158

Published: 2007

Journal Articles

Prevention of Ph + Acute Lymphoblastic Leukemia by Nanoparticulate Delivery of a DNA Vaccine in Syngeneic Mice.

Joachim Koechling, MD, Yvonne Rott, Stefanie Arndt, Jordan Green, Ph.D., Daniel Anderson, Ph.D., Robert Langer, Ph.D., Renata Stripecke, Ph.D., Burghardt Wittig, M.D. Ph. D, Manuel Schmidt

Blood (2007) 110 (11): 5135.

https://doi.org/10.1182/blood.V110.11.5135.5135

Published: 2007

Journal Articles

Preliminary Results from a Phase 2 Trial of AG-858, an Autologous Heat Shock Protein-Peptide Vaccine, in Combination with Imatinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CML) Resistant to Prior Imatinib Monotherapy.

David Marin, MD, Michael Mauro, MD, John Goldman, MD, Brian Druker, MD, Steven Devine, MD, Richard E. Clark, MD, Ronald Paquette, MD, Asad Bashey, MD, Martin S. Tallman, MD, April Dovholuk, Axel Hoos, MD, PhD, Pramod Srivastava, PhD

Blood (2005) 106 (11): 1094.

https://doi.org/10.1182/blood.V106.11.1094.1094

Published: 2005

Journal Articles

Impact of Rantes and MCP-1 Chemokines on In Vivo Basophilic Cell Recruitment in Rat Skin Injection Model and Their Role in Modifying the Protein and mRNA Levels for Histidine Decarboxylase

Pio Conti, Xinzhu Pang, William Boucher, Richard Letourneau, Marcella Reale, Renato C. Barbacane, Jean Thibault, Theoharis C. Theoharides

Blood (1997) 89 (11): 4120–4127.

https://doi.org/10.1182/blood.V89.11.4120

Published: 1997

NARROW

Preliminary Results from a Phase 1/2 Study of DSP-7888, a Novel WT1 Peptide-Based Vaccine, in Patients with Myelodysplastic Syndrome (MDS)

L-Asparaginase-Induced Allergy in Mice: Effects of Concomitant Drugs and Anti-IgE Antibody

Next Generation XPO1 Inhibitor KPT-8602 for the Treatment of Drug-Resistant Multiple Myeloma

A Phase 1/2 Study of WT1 Peptide Cancer Vaccine WT4869 in Patients with Myelodysplastic Syndromes (MDS)

Prevention Of Relapse In Acute Myeloid Leukemia By Dendritic Cell Vaccination: Report on a Phase II Study With 29 Patients

Human Umbilical Cord Blood (HUCB) Derived Pluripotent Stem Cells Enhances Wound Healing

WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia

Peptide-Vaccine Treatment Associated with TKI Therapy in Patients with CML Is Able to Induce Immunologic, Cytogenetic and Molecular Responses: a Single Center Experience with Long-Term Follow up.

Immunogenicity and Antileukemic Activity of Dendritic Cells Electroporated with Wilms’ Tumor WT1 mRNA: A Phase I/II Trial in Acute Myeloid Leukemia

Impact of Autologous Dendritic Cell Immunotherapy (Arcelis ™ ) on B Cell Subsets in HIV-1-Infected Subjects Receiving Antiretroviral Therapy

Vaccination of Acute Myeloid Leukemia Patients with Dendritic Cells Electroporated with mRNA Encoding the Wilms’ Tumor Protein WT1: A Phase I/II Trial.

Prevention of Ph + Acute Lymphoblastic Leukemia by Nanoparticulate Delivery of a DNA Vaccine in Syngeneic Mice.

Preliminary Results from a Phase 2 Trial of AG-858, an Autologous Heat Shock Protein-Peptide Vaccine, in Combination with Imatinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CML) Resistant to Prior Imatinib Monotherapy.

Impact of Rantes and MCP-1 Chemokines on In Vivo Basophilic Cell Recruitment in Rat Skin Injection Model and Their Role in Modifying the Protein and mRNA Levels for Histidine Decarboxylase

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only